Immunizations could be administered within minutes where and when a disease is breaking out.
Vaccines combat diseases and protect populations from outbreaks, but the life-saving technology leaves room for improvement. Vaccines usually are made en masse in centralized locations far removed from where they will be used. They are expensive to ship and keep refrigerated and they tend to have short shelf lives.
University of Washington engineers hope a new type of vaccine they have shown to work in mice will one day make it cheaper and easy to manufacture on-demand vaccines for humans. Immunizations could be administered within minutes where and when a disease is breaking out.
“We’re really excited about this technology because it makes it possible to produce a vaccine on the spot. For instance, a field doctor could see the beginnings of an epidemic, make vaccine doses right away, and blanket vaccinate the entire population in the affected area to prevent the spread of an epidemic,” said François Baneyx, a UW professor of chemical engineering and lead author of a recent paper published online in the journal Nanomedicine.
In typical vaccines, weakened pathogens or proteins found on the surface of microbes and viruses are injected into the body along with compounds called adjuvants to prepare a person’s immune system to fight a particular disease. But standard formulations don’t always work, and the field is seeking ways to manufacture vaccines quicker, cheaper and tailored to specific infectious agents, Baneyx said.
The UW team injected mice with nanoparticles synthesized using an engineered protein that both mimics the effect of an infection and binds to calcium phosphate, the inorganic compound found in teeth and bones. After eight months, mice that contracted the disease made threefold the number of protective “killer” T-cells – a sign of a long-lasting immune response – compared with mice that had received the protein but no calcium phosphate nanoparticles.
The nanoparticles appear to work by ferrying the protein to the lymph nodes where they have a higher chance of meeting dendritic cells, a type of immune cell that is scarce in the skin and muscles, but plays a key role in activating strong immune responses.
In a real-life scenario, genetically engineered proteins based on those displayed at the surface of pathogens would be freeze-dried or dehydrated and mixed with water, calcium and phosphate to make the nanoparticles. This should work with many different diseases and be especially useful for viral infections that are hard to vaccinate against, Baneyx said.
He cautioned, however, that it has only been proven in mice, and the development of vaccines using this method hasn’t begun for humans.
The Latest on: Vaccines
via Google News
The Latest on: Vaccines
- Another Day, Another Meme to Debunk: Vaccines for the Bovine Coronavirus Will Not Cure COVID-19on March 24, 2020 at 3:12 pm
During any big news event, Facebook becomes even more of a pit of toxic disinformation than it is on a relatively normal day. That said, there is one particular meme that I saw pop up a few times ...
- Beware of Fraudulent Coronavirus Tests, Vaccines and Treatmentson March 24, 2020 at 1:06 pm
Because COVID-19 has never been seen in humans before, there are currently no vaccines to prevent or drugs to treat COVID-19 approved by the U.S. Food and Drug Administration (FDA). The FDA is working ...
- Drugmakers are developing coronavirus vaccines in record time — but it will still be months before one is availableon March 24, 2020 at 11:56 am
Drug companies are working on developing a coronavirus vaccine at record speed. But it could still be a while before we see one ready for use.
- Recombinant Vaccines Market Report 2020- Industry Trends, Global Size, Share Investment, Research Report, Growth and Forecast to 2023on March 24, 2020 at 6:50 am
В настоящее время (данные на 24.03.2020) в Израиле зарегистрировано 1.930 случаев заражения опасным для человека коронавирусом нового типа COVID-19.В последние сутки вирусом заразилось 488 человек. 53 ...
- Vaccines, drugs: What will work against COVID-19?on March 24, 2020 at 4:52 am
The names of several drugs have come up as possible treatments for the novel coronavirus, also known as COVID-19, in consecutive press conferences by President Donald Trump.There is a vaccine for the ...
- Travel Vaccines Market Size, Drivers and Key Players: Pfizer, Sanofi, GlaxoSmithKline, Merck, AstraZeneca, Abbotton March 24, 2020 at 2:50 am
Mar 24, 2020 (Xherald via COMTEX) -- The Travel Vaccines Market is growing at a faster pace with substantial growth rates over the last few years and is ...
- Coronavirus treatments: Everything you need to know about chloroquine and vaccineson March 23, 2020 at 4:34 pm
Berti Blockwardt stellt sich wieder und weiter in den "Dienst der Gesellschaft" - und schreibt alle auf seine Liste, die sich nicht an seine ganz persönliche Auslegung von Ausgangssperren und Sicherhe ...
- Coronavirus: Government gives £10.5m to promising projects including vaccineson March 23, 2020 at 11:58 am
One of the new vaccines, developed by the University of Oxford, will be supported through pre-clinical and clinical trials ...
- Trudeau promises $192M on developing vaccines for coronaviruson March 23, 2020 at 8:25 am
Prime Minister Justin Trudeau says Canada is spending $192 million on developing and producing vaccines for the novel coronavirus. He says being prepared to mass-produce a vaccine, no matter who ...
- WHO Issues Advice On Whether Pneumonia Vaccines Protect You Against COVID-19 Infections?on March 23, 2020 at 6:41 am
Coronavirus has become akin to apocalyptic movies that many people love to watch except that this is no movie and it is actually happening. With the UK’s total number of cases now standing at 5,683 ...
via Bing News